Summary
Cygnal Therapeutics
Founded in 2017
Description
Cygnal Therapeutics is a biotechnology company founded in 2017 by Flagship Pioneering. They are focused on developing drugs in the field of exoneural biology, starting with cancer and inflammatory diseases. Their Exoneural Medicine Platform allows the...
Strengths
- Cygnal Therapeutics has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Cygnal Therapeutics was founded, the company has grown faster than the industry average
Annual Revenue
Cygnal Therapeutics's annual revenue
$10195000
Based on Kona Equity data
-
Revenue per employee
$509750
-
Variance of revenue growth
0.01
-
Annual revenue growth since founding
$1456428
-
Revenue growth rate from first known quarter to current
29.2%
Employee Count
20 employees
-
Employee growth rate from first known quarter to current
29.4%
Executives
Daniel Blom
Vice President, Biologics Drug Discovery
d**@cygnaltx.comDouglas Campbell
Vice President, Finance
d**@cygnaltx.comJared Subiono
Research Assistant
j**@cygnaltx.comKidist Aklilu
Senior Researcher Associate At Therapeutics
k**@cygnaltx.comNicole Carta
Vice President, Human Resources
n**@cygnaltx.comRyan Zhang
Research Co Op Associate
r**@cygnaltx.comDeanna Sumrein
Recruiting Coordinator
d**@cygnaltx.comLjiljana Minwalla
Senior Vice President
l**@cygnaltx.comEugene Chekler
Director, Medicinal Chemistry
e**@cygnaltx.comJames Searson
Research Associate
j**@cygnaltx.comPauline Mcgowan
Senior VP, Finance
p**@cygnaltx.comGuang Liu
Director, Hit Generation Science
g**@cygnaltx.comIshita Majumdar
Scientist
i**@cygnaltx.comKai-Chih Huang
Imaging Data Scientist
k**@cygnaltx.comTimothy Zheng
Senior Vice President, Biology
t**@cygnaltx.comJijun Dong
Executive Director
j**@cygnaltx.comAndrea Park
Intern
a**@cygnaltx.comSarah Nesti
Senior Research Associate
s**@cygnaltx.comAlexandria Fink
Research Associate
a**@cygnaltx.comAnthony Bombard
Manager, Office of the President and Chief Executive Officer
a**@cygnaltx.comMandana Abbassi
Research Principal & Vivo Associate
m**@cygnaltx.comKiley Cuoto
Scientist
k**@cygnaltx.comDaniela Maiz
Research Associate
d**@cygnaltx.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Cygnal Therapeutics
- Category: Biotechnology
- Industry: Biotechnology Company
- SIC: 80; 283
- NAICS: 541; 5417
See similar companies
-
By City Cambridge Small Biotechnology Company in Cambridge Mid-size Biotechnology Company in Cambridge Biotechnology in Cambridge Small Biotechnology in Cambridge Mid-size Biotechnology in Cambridge
-
By State MA Small companies in MA Biotechnology in MA Small Biotechnology in MA Mid-size Biotechnology in MA Small Biotechnology Company in MA Mid-size Biotechnology Company in MA
-
By Category Biotechnology Small Biotechnology Mid-size Biotechnology
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Biotechnology and Biotechnology Company
-
Firmographic data G Score of 6 Founded in 2017 SIC: 80 SIC: 283 NAICS: 541 NAICS: 5417 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Cygnal Therapeutics's headquarters are located at 325 Vassar St, Ste 2B Cambridge, MA 02139.
Cygnal Therapeutics's official website is cygnaltx.com
Cygnal Therapeutics's annual revenue is $10.2 M.
Cygnal Therapeutics's SIC: 80; 283
Cygnal Therapeutics's NAICS: 541; 5417.
Cygnal Therapeutics has 20 employees
Cygnal Therapeutics is in the industry of Biotechnology.